Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 21

recruiting
3 972
countries
28
conditions
2 103

1 070 trials match your criteria

Study on Treating Graves' Eye Disease with Diclofenac or Simvastatin for Patients with Mild to Moderate Symptoms

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Simvastatin

Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab

Study of Digitoxin with Chemotherapy for Patients with Inoperable Pancreatic Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Digitoxin

Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin

Study of daridorexant and buprenorphine combination treatment for patients with opioid use disorder

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Buprenorphine

Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Human papillomavirus type 11 L1 protein

Clonidine Hydrochloride for Pain Relief During Eye Exams in Premature Infants with Retinopathy of Prematurity

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Clonidine Hydrochloride

Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Eplontersen
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin

Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Crisantaspase

Endometrial cancer+5

Recruiting

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib

Study on Preventing Atrial Fibrillation Recurrence After Cardioversion Using Dapagliflozin in Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.